X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
STRIDES PHARMA SCIENCE Announces Quarterly Results (4QFY19); Net Profit Up 7919.8%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STRIDES PHARMA SCIENCE Announces Quarterly Results (4QFY19); Net Profit Up 7919.8%
Mon, 13 May

STRIDES PHARMA SCIENCE has announced its results for the quarter ended March 2019. Here is a detailed performance review of the same:

STRIDES PHARMA SCIENCE Quarterly Financials

No. of Mths
Qtr. Ending
3
Mar-18*
3
Dec-18*
3
Mar-19*
QoQ ChangeYoY Change
Net SalesRs m6,6427,9458,3975.7%26.4%
Other incomeRs m21881461657.8%-33.1%
TurnoverRs m6,8607,9538,5437.4%24.5%
ExpensesRs m5,7766,6746,8082.0%17.9%
Gross profitRs m6491,2781,67931.3%158.8%
DepreciationRs m4434074387.7%-1.2%
InterestRs m45550162725.1%37.8%
Profit before taxRs m-31379760100.6%
TaxRs m-406311174.6%
Profit after taxRs m8316650105.8%7919.8%
Gross profit margin%9.816.120.0
Effective tax rate%125.816.714.5
Net profit margin%0.14.07.6
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 26.4% on a year-on-year (YoY) basis. The expenses were up by 17.9% YoY during the same period.
  • The company's operating profit increased by 158.8% YoY during the quarter. Consequently, operating profit margins witnessed a growth and stood at 20.0% in 4QFY19 as against 9.8% in 4QFY18.
  • Depreciation charges declined by 1.2% and finance costs increased by 37.8% YoY, respectively.
  • Other income declined by 33.1% YoY during the quarter.
  • Net profit for the quarter increased by 7919.8% YoY. Net profit margins during the quarter increased from 0.1% in 4QFY18 to 7.6% in 4QFY19.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 5.7% on a quarter-on-quarter (QoQ) basis. The expenses were up by 2.0% QoQ during the same period.
  • The company's operating profit increased by 31.3% QoQ during the quarter. Consequently, operating profit margins witnessed a growth and stood at 20.0% in 4QFY19 as against 16.1% in 3QFY18.
  • Net profit for the quarter increased by 105.8% QoQ, while net profit margins increased from 4.0% in 3QFY18 to 7.6% in 4QFY19.

To see how STRIDES PHARMA SCIENCE has performed over the last eight quarters, please visit here.

STRIDES PHARMA SCIENCE Share Price Performance

Over the last one year, STRIDES PHARMA SCIENCE share price has moved up from Rs 531.7 to Rs 446.0, registering a Loss of Rs 85.7 or around 16.1%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 13,624.8 (down 1.3%). Over the last one year it has moved up from 13,369.7 to 13,624.8, a gain of 255 points (up 1.9%).

Overall, the S&P BSE SENSEX is up 6.5% over the year.

Current Valuations

At the current price of Rs 446.0, the price to earnings (P/E) ratio of STRIDES PHARMA SCIENCE stands at 25.2 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 1.1 times.

Equitymaster requests your view! Post a comment on "STRIDES PHARMA SCIENCE Announces Quarterly Results (4QFY19); Net Profit Up 7919.8%". Click here!

  

Related Views on News

STRIDES PHARMA SCIENCE Announces Quarterly Results (3QFY19); Net Profit Down 27.5% (Quarterly Result Update)

Jan 30, 2019 | Updated on Jan 30, 2019

For the quarter ended December 2018, STRIDES PHARMA SCIENCE has posted a net profit of Rs 316 m (down 27.5% YoY). Sales on the other hand came in at Rs 8 bn (up 6.1% YoY). Read on for a complete analysis of STRIDES PHARMA SCIENCE's quarterly results.

STRIDES PHARMA SCIENCE 2017-18 Annual Report Analysis (Annual Result Update)

Dec 19, 2018 | Updated on Dec 19, 2018

Here's an analysis of the annual report of STRIDES PHARMA SCIENCE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of STRIDES PHARMA SCIENCE. Also includes updates on the valuation of STRIDES PHARMA SCIENCE.

STRIDES PHARMA SCIENCE Announces Quarterly Results (2QFY19); Net Profit Down 72.2% (Quarterly Result Update)

Nov 6, 2018 | Updated on Nov 6, 2018

For the quarter ended September 2018, STRIDES PHARMA SCIENCE has posted a net profit of Rs 54 m (down 72.2% YoY). Sales on the other hand came in at Rs 7 bn (down 26.4% YoY). Read on for a complete analysis of STRIDES PHARMA SCIENCE's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

These 3 Smallcap Stocks are Set to Make the Most of Smallcap Rebound(Profit Hunter)

Jul 9, 2019

As the sense of normalcy returns to the markets, the rebound in the quality smallcaps could be huge.

2 Stocks from Super Investor Sanjay Bakshi's Portfolio You Can Bet On...(The 5 Minute Wrapup)

Jul 12, 2019

Despite the current fear prevailing in the markets, both these stocks have the potential to deliver in 4-5 years.

After Disappointing Budget, Here's a Document that Concerns Largecap and Smallcap Investors(The 5 Minute Wrapup)

Jul 8, 2019

A new 'definition' of the stock universe that triggered the smallcap sell-off is back with the latest list...

Union Budget 2019-2020: More Style Over Substance(The 5 Minute Wrapup)

Jul 5, 2019

Did the Union Budget announce measures to stimulate the economy and bolster corporate earnings growth?

Here's What to Do with Falling Small Cap Stocks(Profit Hunter)

Jul 10, 2019

There are some great buying opportunities in the market right now - and the small cap space is your best bet.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

STRIDES PHARMA SCIENCE SHARE PRICE


Jul 18, 2019 (Close)

TRACK STRIDES PHARMA SCIENCE

  • Track your investment in STRIDES PHARMA SCIENCE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STRIDES PHARMA SCIENCE

STRIDES PHARMA SCIENCE - ELDER PHARMA COMPARISON

COMPARE STRIDES PHARMA SCIENCE WITH

MARKET STATS